Clinical Indications of Recombinant Human Erythropoietin in a Single Center: A 10-Year Retrospective Study
In the 1980s, recombinant human erythropoietin (rhEPO) began to be used in clinical practice. In this study, the clinical application of rhEPO from single-center in recent ten years was reviewed, and the scope of indications and clinical efficacy were evaluated. The medical records of 35829 in-patie...
Saved in:
Main Authors: | Xiao-Zhen Guan (Author), Lei-Li Wang (Author), Xue Pan (Author), Li Liu (Author), Xiao-Lin Sun (Author), Xiao-Juan Zhang (Author), De-Qing Wang (Author), Yang Yu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Recombinant Human Erythropoietin Administration in Premature Infants with Severe Intraventricular Hemorrhage: A Single-Center Experience
by: Ha Na Lee, et al.
Published: (2023) -
Resistance to recombinant human erythropoietin therapy in haemodialysis patients
by: Elísio Costa, et al.
Published: (2009) -
Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China-a 10-year continuous single-center study
by: Xue-Xiao Bai, et al.
Published: (2020) -
CORRECTION OF ISCHEMIC DAMAGE TO THE RETINA ON APPLICATION OF PHARMACOLOGICAL PRECONDITIONING OF RECOMBINANT ERYTHROPOIETIN
by: Anna Shabelnikova
Published: (2016) -
Clinical characteristics of patients with prenatal hydronephrosis in early postnatal period: a single center retrospective study
by: Song-Lei Gu, et al.
Published: (2023)